Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 4 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Pancreatic Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Lymphoma, T-Cell, Peripheral 2Lymphoma, Extranodal NK-T-Cell 2Biliary Tract Neoplasms 2Thoracic Neoplasms 1Squamous Non-small-cell Lung Cancer 1Oligospermia 1Non-small Cell Lung Cancer Metastatic 1Neoplasms 1Neoplasm Metastasis 1Nasopharyngeal Neoplasms 1Lymphohistiocytosis, Hemophagocytic 1Lung Neoplasms 1Lung Diseases 1Fibrosis 1Carcinoma, Transitional Cell 1Carcinoma, Renal Cell 1Adenocarcinoma Pancreas 1Adenocarcinoma 1

Interventions

Vinorelbine 1Gemcitabine 1Gefitinib 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Non-small Cell Lung Cancer Metastatic × Gemcitabine × Clear all
NCT02299765 2017-11-27

Intercalating and Maintenance Gefitinib in Combination With Chemotherapy for Advanced EGFR-mutant NSCLC

Sichuan University

Phase 4 Terminated
61 enrolled
Thoracic

Non-small Cell Lung Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡